References
- Henter J-I, Ellinder G, Lubeck P-O, Aost A. Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis. Pediatric Hematology and Oncology, this issue
- Pui C H, Ribeiro R C, Hancock M L. Acute myeloid leukemia in children treated with epipodophy-llotoxins for acute lymphoblastic leukemia. New Engl J Med. 1991; 325: 1682–1687
- Hawkins M M, Kinnier Wilson L M, Stovall M A. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukemia after childhood cancer. B Med J. 1992; 304: 951–958
- Ross W, Rowe T, Glisson B, Yalowich J, Liu L. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res. 1984; 44: 5857–5860
- Pedersen-Bjergaard J, Hansen SW, Larsen SO, Daugaard G, Philip P, Rørth M. Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumors. Lancet 1991; 338: 359–363